News Daily News Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet) Michael O'Riordan January 08, 2019
News Daily News Stroke Risk Increases Over Time in Many Patients With A-fib Todd Neale January 08, 2019
News Daily News Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences Michael O'Riordan January 07, 2019
News Daily News European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs Shelley Wood December 18, 2018
News Conference News WCC 2018 Is It Time to Loosen Restrictions on Saturated Fats and Salt? Todd Neale December 14, 2018
News Conference News WCC 2018 Man’s Best Friend, Especially After an MI or Stroke Todd Neale December 11, 2018
News Conference News WCC 2018 True Resistant Hypertension Is Prevalent Worldwide Todd Neale December 07, 2018
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Conference News WCC 2018 WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai Todd Neale December 05, 2018
News Daily News SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients Michael O'Riordan December 04, 2018
News Daily News Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests Michael O'Riordan December 03, 2018
News Daily News Quality of Anticoagulation Therapy Lower in Black Patients With A-fib Todd Neale December 03, 2018
News Daily News FDA Warns of Stroke and Arterial Dissection Risk With MS Drug L.A. McKeown November 29, 2018
News Daily News PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study Michael O'Riordan November 23, 2018
News Daily News Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints Caitlin E. Cox November 21, 2018
News Conference News AHA 2018 EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
News Conference News AHA 2018 TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG Shelley Wood November 13, 2018